These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16087142)

  • 41. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
    Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
    Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
    Patel JV; Lee KW; Tomson J; Dubb K; Hughes EA; Lip GY
    Int J Cardiol; 2007 Jan; 115(1):42-5. PubMed ID: 16781788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk stratification and survival in post myocardial infarction patients: a large prospective and multicenter study in Japan.
    Ohno J; Watanabe E; Toyama J; Kawamura T; Ohno M; Kodama I
    Int J Cardiol; 2004 Feb; 93(2-3):263-8. PubMed ID: 14975557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellner Y
    Pharmacoeconomics; 2006; 24(8):783-95. PubMed ID: 16898848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Omega-3 fatty acids in cardiology. Latest developments].
    von Schacky C
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial.
    Singer P; Wirth M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):153-9. PubMed ID: 15253884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omega-3 in antiarrhythmic therapy : cons position.
    Borghi C; Pareo I
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):207-11. PubMed ID: 23430665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter by McEvoy regarding article, "Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both".
    McEvoy JW
    Circulation; 2011 May; 123(18):e585; author reply e586-7. PubMed ID: 21555720
    [No Abstract]   [Full Text] [Related]  

  • 49. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction.
    Christensen JH; Korup E; Aarøe J; Toft E; Møller J; Rasmussen K; Dyerberg J; Schmidt EB
    Am J Cardiol; 1997 Jun; 79(12):1670-3. PubMed ID: 9202361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study.
    Rauch B; Schiele R; Schneider S; Gohlke H; Diller F; Gottwik M; Steinbeck G; Heer T; Katus H; Zimmer R; Erdogan A; Pfafferott C; Senges J;
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):365-75. PubMed ID: 17124558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
    Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J;
    Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F;
    J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the reanalysis of the GISSI-Prevenzione.
    Leaf A
    Circulation; 2002 Apr; 105(16):1874-5. PubMed ID: 11997268
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter by Alter and Rupp regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
    Alter P; Rupp H
    Circulation; 2011 Jul; 124(1):e23; author reply e24-5. PubMed ID: 21730314
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
    Halcox JP
    Circulation; 2011 Jul; 124(1):e21; author reply e24-5. PubMed ID: 21730312
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of dietary fat intake in sudden death: reduction of death with omega-3 fatty acids.
    Lee KW; Hamaad A; MacFadyen RJ; Lip GY
    Curr Cardiol Rep; 2004 Sep; 6(5):371-8. PubMed ID: 15306094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter by Papageorgiou et al regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
    Papageorgiou N; Tousoulis D; Stefanadis C
    Circulation; 2011 Jul; 124(1):e22; author reply e24-5. PubMed ID: 21730313
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of n-3 polyunsaturated fatty acids on risk reduction of sudden death.
    Jones PJ; Lau VW
    Nutr Rev; 2002 Dec; 60(12):407-9. PubMed ID: 12521145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-3 polyunsaturated fatty acids and cardiac mortality.
    Singleton CB; Walker BD; Campbell TJ
    Aust N Z J Med; 2000 Apr; 30(2):246-51. PubMed ID: 10833118
    [No Abstract]   [Full Text] [Related]  

  • 60. Omega-3 polyunsaturated fatty acids for patients at risk of sudden cardiac death and ventricular arrhythmias: trial sequential analysis.
    Messori A; Fadda V; Maratea D; Trippoli S
    Heart Lung; 2013; 42(5):391-2. PubMed ID: 23849506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.